This filing details transactions by Matthew L. Scruggins, a director at Catalyst Bancorp, Inc. (CLST). On December 18, 2025, Scruggins acquired 332 shares of Common Stock as a gift from his mother, increasing his post-transaction shares to 24,854. The filing also notes his indirect ownership of 10,000 shares through hi...

Peter Diamandis, a director at Celularity Inc., acquired 67,416 shares of Class A Common Stock on December 19, 2025. This acquisition was made through restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan, which vested on the same date. The transaction was reported on a Form 4 filin...

This filing details a Form 4 transaction for Celularity Inc., filed on December 22, 2025. Reporting owner Geoffrey M.D. Ling, a director, acquired 67,416 shares of Class A Common Stock on December 19, 2025. The acquisition was made at a price of $0.00 per share, with the shares representing vested restricted stock unit...

This filing details a transaction by Diane L. Parks, a director at Celularity Inc., on December 19, 2025. Ms. Parks acquired 67,416 shares of Class A Common Stock through the vesting of restricted stock units (RSUs) granted under the Celularity Inc. 2021 Equity Incentive Plan. These RSUs became exercisable on the trans...

This filing details stock transactions by Robert P. Mauch, President & CEO of Cencora, Inc. On December 18, 2025, Mauch acquired 3,763 shares of Common Stock through the exercise of a stock option at a price of $86.09 per share, bringing his total post-transaction shares to 73,155. Concurrently, he disposed of 5,096 sh...

This filing details stock transactions by Mark Zoradi, a director at Cinemark Holdings, Inc. The transactions primarily involve transfers of "Common Stock" to a family trust, with some purchases and sales also noted. Several transactions were corrected from previous filings to accurately reflect their indirect nature t...

This SEC Form 4 filing documents Steve Rosenberg's (Director of Cinemark Holdings, Inc.) systematic transfers of common stock to family trusts and investment entities over a 15-year period from 2009 to 2024. The filing shows Rosenberg transferred shares for no consideration to the Rosenberg Family Trust, where he serve...

This Form 4 filing corrects a previous filing from November 12, 2025. The original filing incorrectly reported a gift/disposition of 11,900 shares of Cinemark Holdings, Inc. common stock as a direct disposition. This correction clarifies that the disposition was made through a family trust where Steve Rosenberg serves ...

This filing details a transaction by Ximena G. Humrichouse, a director at Cinemark Holdings, Inc. (CNK). On May 16, 2025, Ms. Humrichouse disposed of 1700 shares of Common Stock. The transaction code is 'G', indicating a disposition. The price per share was $0.00. Following this transaction, Ms. Humrichouse directly ow...

This filing details transactions made by Syufy Raymond W, a director at Cinemark Holdings, Inc. On July 11, 2022, 34,105 shares of common stock were transferred to a family trust for no consideration. On July 5, 2024, an additional 16,273 shares were transferred to the same trust under similar conditions. The latest tr...

On April 23, 2025, Fernandes Valmir, Pr - Cinemark International at Cinemark Holdings, Inc., transferred 88,130 shares of common stock to a revocable family trust for which Valmir is a trustee. The transfer was made for no consideration. Valmir remains an indirect beneficial owner of the securities held by the trust. P...

Raymond W. Syufy, a director at Cinemark Holdings, Inc. (CNK), reported several transactions involving the company's common stock. On July 11, 2022, Syufy transferred 34,105 shares to a family trust for no consideration. On June 15, 2023, he acquired 7,867 shares as part of an annual restricted stock award. On July 5, ...

Mary Ann Halford, a director at Cineverse Corp., acquired 32,413 shares of Class A Common Stock on December 8, 2025, with a transaction price of $0. This acquisition is part of her annual retainer for board service commencing October 1, 2025. The shares vest quarterly, with the first vesting on December 31, 2025, provi...

This filing details a transaction by Kevin Cronin, a director at CROSS COUNTRY HEALTHCARE INC (CCRN). On December 18, 2025, Mr. Cronin acquired 162,672 shares of Common Stock through a grant of restricted stock units (RSUs). These RSUs vest in three equal installments on December 18, 2026, March 31, 2027, and March 31,...

This Form 4 filing details transactions by Frederick Ernest Ehrsam III, a director at Coinbase Global, Inc., on December 18, 2025. The transactions were conducted under a Rule 10b5-1 trading plan. Ehrsam III converted 1,375 shares of Class B Common Stock into 1,375 shares of Class A Common Stock. Concurrently, he sold ...

Charles L. Treadway, President and CEO of CommScope Holding Company, Inc., reported a disposition of 478,174 shares of Common Stock on December 18, 2025. The transaction, coded as "F," occurred at a price of $17.85 per share. Following this transaction, Treadway owns 5,430,637 shares. A portion of the disposed shares w...

This filing details a transaction by Lorentzen Kyle David, EVP & CFO of CommScope Holding Company, Inc. On December 18, 2025, Mr. David disposed of 136,333 shares of Common Stock at a price of $17.85 per share. This disposal was to cover taxes incurred upon the vesting of restricted stock units and performance share un...

This filing details a transaction by Koen ter Linde, SVP & President, CCS of CommScope Holding Company, Inc. On December 18, 2025, ter Linde disposed of 171,977 shares of Common Stock. The shares were sold at a price of $17.85 per share. This disposal was to cover taxes incurred upon the vesting of restricted stock uni...

This filing details a transaction by Mingle Robyn T, SVP and Chief HR Officer of CommScope Holding Company, Inc., involving 122,531 shares of Common Stock on December 18, 2025. The shares were disposed of at a price of $17.85 per share, totaling 122,531 shares. These shares were withheld to cover taxes incurred upon th...

This filing details a transaction by Giordano Bartolomeo, SVP & President, NICS, on December 18, 2025. Bartolomeo disposed of 74,206 shares of Common Stock, with 74,206 shares withheld to cover taxes incurred upon the vesting of restricted stock units and performance share units. The transaction price was $17.85 per sh...

On December 8, 2025, CDT Equity Inc. entered into a Sale and Purchase Agreement with Corvus Capital Limited. Pursuant to this agreement, CDT Equity Inc. issued 224,800 shares of common stock and pre-funded warrants to purchase up to 3,685,815 shares of common stock to Corvus Capital Limited. This transaction was part o...

Peter K. Cosgrove, Executive Vice President & CCO of CHEMUNG FINANCIAL CORP (CHMG), reported a disposition of 117 shares of COMMON STOCK on December 19, 2025, at a price of $57.81 per share. Following this transaction, Cosgrove owns 6158 shares directly. Another disposition of 106 shares of COMMON STOCK was also report...

Grigorios Siokas, CEO, Director, and 10% owner of Cosmos Health Inc., acquired 88,314 shares of common stock on December 19, 2025. The acquisition was part of a debt exchange agreement where Mr. Siokas exchanged $43,000 of debt owed to him by the company for these shares at a fair market value of $0.4869 per share. Fol...

This filing details stock transactions by Stephen Cotton, CEO and Director of Aqua Metals, Inc. On December 18, 2025, Mr. Cotton acquired 14,749 shares of common stock with a transaction price of $0.00. This acquisition was fully vested. In a separate transaction on the same day, 6,247 shares were disposed of (transact...

This filing details transactions by Sameer K. Gandhi, a director at CrowdStrike Holdings, Inc. On December 19, 2025, Mr. Gandhi acquired 31 shares of Class A common stock. This acquisition was part of a plan to receive fully vested restricted stock units (RSUs) in lieu of quarterly cash retainers, which immediately con...